Loading patent…
AssigneeArQule, Inc.
InventorsJean-Marc Lapierre, Sudharshan Eathiraj, Nivedita Namdev, Brian Schwartz, Yusuke Ota, Takayuki Momose, Tomoyuki Tsunemi, Hiroaki Inagaki, Kiyoshi Nakayama
Estimating the term…
The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, tautomer, prodrug, solvate, metabolite, polymorph, analog or derivative thereof, which modulates the activity of BTK, a pharmaceutical composition comprising the compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.
A method of treating chronic lymphoid leukemia, comprising administering to a patient in need thereof a therapeutically effective amount of a compound of Formula (I):
Dependencies are inferred from the claim text.